Home / Resource Library / Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 studyMosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study